Latest Sales Performance News

Page 3 of 12
Mirvac Group reported robust operational results in 3Q26, driven by a 28% jump in residential sales, high occupancy across its investment portfolio, and a successful $630 million capital raise for its wholesale office fund. The company reaffirmed its FY26 guidance amid cautious risk management.
Eva Park
Eva Park
23 Apr 2026
BPH Global has secured a key coastal site in South Sulawesi to boost its seaweed cultivation and processing capabilities, underpinning its vertical integration strategy across food and bio stimulant markets.
Ada Torres
Ada Torres
22 Apr 2026
Freehill Mining’s aggregate materials sales surged in March, with quarterly sales up 60%, while the company prioritises mine planning and permitting for its Blanco y Negro copper-gold project.
Maxwell Dee
Maxwell Dee
16 Apr 2026
Ryman Healthcare’s FY26 retirement living sales hit 1,410 ORAs, aligning with guidance despite a Q4 dip in new sales. The company reports robust aged care occupancy and expects free cash flow near NZD 180 million.
Ada Torres
Ada Torres
15 Apr 2026
Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.
Ada Torres
Ada Torres
8 Apr 2026
Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.
Ada Torres
Ada Torres
7 Apr 2026
Xenitra Limited has secured a $30 million AUD sales agreement for Danone products with Rockcheck Group and established its Australian subsidiary as an authorised supplier, marking a major step in its China market strategy.
Victor Sage
Victor Sage
30 Mar 2026
RLF AgTech reported a 5% increase in revenue to $14.3 million for the half-year ending December 2025, while posting a $4.08 million loss reflecting a deliberate investment phase. The company also appointed Stuart Upton as CEO to lead its next growth chapter.
Ada Torres
Ada Torres
27 Feb 2026
SomnoMed Limited has reported a return to profitability for the half-year ending December 2025, posting a $792,000 net profit after tax on the back of a 13% revenue increase. Despite the positive turnaround, the company has elected not to pay an interim dividend.
Ada Torres
Ada Torres
27 Feb 2026
Summerset Group Holdings delivered a record underlying profit of NZ$234.2 million in FY25, driven by strong sales and portfolio growth, while advancing its Australian village developments. Despite a dip in IFRS net profit due to portfolio revaluations, the company maintains a positive outlook with high resident satisfaction and sustainability milestones.
Eva Park
Eva Park
27 Feb 2026
Jatcorp Limited reported a strong 36% revenue increase to $23 million for the half-year ended December 2025, narrowing its net loss and expanding its footprint across Asia Pacific markets despite ongoing legal challenges in China.
Victor Sage
Victor Sage
26 Feb 2026
US Masters Residential Property Group reported a $57.3 million net loss for 2025 amid a strategic shift to wind down operations by selling its entire US residential property portfolio by the end of 2026. The Group surpassed its aggressive 2025 sales target, setting the stage for capital returns to security holders.
Eva Park
Eva Park
26 Feb 2026

Browse the archive

Full archive